This page shows the latest STING news and features for those working in and with pharma, biotech and healthcare.
started working on STING drugs with potential in auto-immune and inflammatory diseases. ... Eli Lilly, for example, paid $12m upfront in a $620 million deal with Aduro Biotech at the end of 2018 for STING inhibitors, focusing on autoimmune diseases.
Novartis paid $200m upfront for rights to Aduro’s STING programme in 2015. ... pipeline. Meanwhile, Mavupharma isn’t the only company trying to develop small-molecule STING agonists.
BMS’ interest was mainly on IFM’s STING and NLRP3 agonists and their potential in boosting immune responses to tumours.
salve its sting.
STING ‘has not stung’. Merck would be an obvious choice for that role, and the analysts also suggest that a deal for SD-101 could be more likely given a lacklustre ... also that the STING agonists were speculated to be more potent based on biology
Looking at some of the new mechanisms on show, Merck/MSD will also have the first clinical results for its STING activator MK-1454, Adaptimmune will have first-in-human results
More from news
Approximately 2 fully matching, plus 18 partially matching documents found.
Among the plethora in the pipeline, Aurigene and BMS are looking at PD-1 inhibitors that can be dosed orally, Novartis, iTeos and Aduro are developing STING agonists that can
It’s like deconstructing a joke; by the end, the punchline loses its sting.
825. Aduro / Novartis. Licence and collaboration. Preclinical cancer immunotherapies targeting the STING (Stimulator of Interferon Genes) pathway.
One such example is Novartis which has CAR-T and checkpoint inhibitor programmes and has now added Aduro's STING (Stimulator of Interferon Genes) technology as an additional string to its ... bow. Aduro has a number of preclinical small molecule cyclic
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
STING - brand / diseases modules. PRECIS - clinical study modules.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...